Regeneron Pharmaceuticals, Inc. is expected to report earnings before market open.
REGN Earnings Date
2026-04-29
Fiscal Quarter Ending
Mar/2026
Consensus EPS Forecast
$6.21
EPS of Last Year
$6.43
Report Date of Last Year
4/29/2025
MarketCap
$79,872,370,631
Number of Analysts
7